Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Microsoft
MSFT
|
+$447M |
| 2 |
Bath & Body Works
BBWI
|
+$338M |
| 3 |
Home Depot
HD
|
+$277M |
| 4 |
GE Aerospace
GE
|
+$267M |
| 5 |
Palo Alto Networks
PANW
|
+$236M |
Top Sells
| 1 |
LNKD
LinkedIn Corporation
LNKD
|
+$714M |
| 2 |
ARMH
ARM HOLDINGS PLC ADS
ARMH
|
+$414M |
| 3 |
Citigroup
C
|
+$376M |
| 4 |
Sherwin-Williams
SHW
|
+$292M |
| 5 |
Starbucks
SBUX
|
+$266M |
Sector Composition
| 1 | Consumer Discretionary | 20.49% |
| 2 | Healthcare | 16.68% |
| 3 | Communication Services | 14.23% |
| 4 | Technology | 14.03% |
| 5 | Financials | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
501
Adaptimmune Therapeutics
ADAP
$13M
| $3.28M | ﹤0.01% |
402,967
-83,981
| -17% | -$683K |
|
502
Berkshire Hathaway Class B
BRK.B
$1.06T
| $3.24M | ﹤0.01% |
22,814
-2,748
| -11% | -$390K |
|
503
Johnson & Johnson
JNJ
$426B
| $3.19M | ﹤0.01% |
29,483
-4,587
| -13% | -$496K |
|
504
Regenxbio
RGNX
$500M
| $3.16M | ﹤0.01% |
292,388
-45,690
| -14% | -$493K |
|
505
Markel Group
MKL
$24.4B
| $3.16M | ﹤0.01% |
3,540
+1,138
| +47% | +$1.01M |
|
506
HF Sinclair
DINO
$9.81B
| $3.15M | ﹤0.01% |
89,183
+35,739
| +67% | +$1.26M |
|
507
Bank of New York Mellon
BK
$73.9B
| $3.13M | ﹤0.01% |
85,070
+5,649
| +7% | +$208K |
|
508
Gartner
IT
$18.7B
| $3.13M | ﹤0.01% |
34,999
+259
| +0.7% | +$23.1K |
|
509
Cardinal Health
CAH
$36B
| $3.1M | ﹤0.01% |
+37,812
| New | +$3.1M |
|
510
General Mills
GIS
$26.9B
| $3.09M | ﹤0.01% |
+48,830
| New | +$3.09M |
|
511
Stryker
SYK
$150B
| $2.91M | ﹤0.01% |
+27,130
| New | +$2.91M |
|
512
Plains GP Holdings
PAGP
$3.66B
| $2.83M | ﹤0.01% |
122,364
-629,045
| -84% | -$14.6M |
|
|
RRMS
513
DELISTED
ROSE ROCK MIDSTREAM L P COM UNIT REPSTG LTD (DE)
RRMS
| $2.69M | ﹤0.01% |
226,690
+107,224
| +90% | +$1.27M |
|
|
INNL
514
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $2.35M | ﹤0.01% |
279,326
+1,887
| +0.7% | +$15.9K |
|
515
SPDR S&P Metals & Mining ETF
XME
$2.33B
| $2.28M | ﹤0.01% |
111,285
+15,067
| +16% | +$309K |
|
516
Targa Resources
TRGP
$34.7B
| $2.27M | ﹤0.01% |
+76,033
| New | +$2.27M |
|
517
Marsh & McLennan
MMC
$99.2B
| $2.23M | ﹤0.01% |
+36,694
| New | +$2.23M |
|
518
Webster Financial
WBS
$10.2B
| $2.2M | ﹤0.01% |
61,238
+258
| +0.4% | +$9.26K |
|
|
IMDZ
519
DELISTED
Immune Design Corp.
IMDZ
| $2.18M | ﹤0.01% |
168,004
-35,448
| -17% | -$461K |
|
520
RLI Corp
RLI
$6.16B
| $2.16M | ﹤0.01% |
64,724
-2,832
| -4% | -$94.7K |
|
521
IBM
IBM
$241B
| $2.15M | ﹤0.01% |
14,853
-11,756
| -44% | -$1.7M |
|
522
Invesco
IVZ
$9.91B
| $2.1M | ﹤0.01% |
68,274
-34,598
| -34% | -$1.06M |
|
523
Danaher
DHR
$139B
| $2.08M | ﹤0.01% |
32,567
+24,109
| +285% | +$1.54M |
|
|
ALPN
524
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $2.06M | ﹤0.01% |
123,180
+196
| +0.2% | +$3.27K |
|
525
Glacier Bancorp
GBCI
$5.75B
| $1.95M | ﹤0.01% |
76,519
+2,735
| +4% | +$69.5K |
|